Jennifer Mock, MD
Obstetrics & Gynecology · Wesley Chapel, NCNPI 1639252026
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Supernus Pharmaceuticals, Inc. accounts for 74.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $427 and has fallen 92.3% since, to $33 in 2025.
Across 22 payments — averaging $37.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$606
- Channel Medsystems, Inc.$66
- Aspira Women's Health Inc$29
- Coopersurgical, Inc.$25
- Organon$18
- Hologic Sales And Service, LLC$16
- plus $54 from 4 others
What the payments were for
- Consulting fees$253%
- Food & beverage$78997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 13 | $606 |
| Channel Medsystems, Inc. | 1 | $66 |
| Aspira Women's Health Inc | 1 | $29 |
| Coopersurgical, Inc. | 1 | $25 |
| Organon | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Bayer | 1 | $14 |
| AbbVie | 1 | $14 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$309
How this compares
$814 in reported general payments places this provider in the 60th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 31 | $1,002 |
| Medroxyprogesterone Acetate | 11 | $316 |
| Gabapentin | 18 | $72 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Wesley Chapel
- Jerry MatkinsCharlotte$481K
- Laura McKainWilmington$475K
- Leslie Hansen-LindnerCharlotte$372K
- Robin MatthewsClyde$217K
- Haywood BrownDurham$165K
- Jack IngeRaleigh$157K
- Geeta SwamyDurham$142K
- Karie LafleurAsheville$135K
- Ty RobinsonHigh Point$114K
- Shan BiscetteCharlotte$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.